A patient at 14 weeks pregnancy, on her routine antenatal panel, tests positive for HBsAg. Which of the following is true about her condition?
Significantly increased maternal morbidity High risk of IUGR and IUD HBsAg is the first serological marker of this illness Lamivudine is the first line drug